Are biomarkers additive to pulmonary embolism severity index for severity assessment in normotensive patients with acute pulmonary embolism?

A Singanayagam; C Scally; M Z Al-Khairalla; L Leitch; L E Hill; J D Chalmers; A T Hill

doi:10.1093/qjmed/hcq168

Are biomarkers additive to pulmonary embolism severity index for severity assessment in normotensive patients with acute pulmonary embolism?

A Singanayagam, C Scally, M Z Al-Khairalla, L Leitch, L E Hill, J D Chalmers, A T Hill

Deanery of Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Biomarkers and clinical prediction rules have been proposed for severity assessment in acute pulmonary embolism (PE).

Original language	English
Pages (from-to)	125-31
Number of pages	7
Journal	QJM: An International Journal of Medicine
Volume	104
Issue number	2
DOIs	https://doi.org/10.1093/qjmed/hcq168
Publication status	Published - 2011

Access to Document

10.1093/qjmed/hcq168

Cite this

@article{8bc4306634014734abf9d8c2f66fe748,

title = "Are biomarkers additive to pulmonary embolism severity index for severity assessment in normotensive patients with acute pulmonary embolism?",

abstract = "Biomarkers and clinical prediction rules have been proposed for severity assessment in acute pulmonary embolism (PE).",

author = "A Singanayagam and C Scally and Al-Khairalla, {M Z} and L Leitch and Hill, {L E} and Chalmers, {J D} and Hill, {A T}",

year = "2011",

doi = "10.1093/qjmed/hcq168",

language = "English",

volume = "104",

pages = "125--31",

journal = "QJM: An International Journal of Medicine",

issn = "1460-2725",

publisher = "Oxford University Press",

number = "2",

}